The associate professor of medicine, Medical College of Wisconsin, discussed advantages of afami-cel and data from the pivotal SPEARHEAD-1 trial.
John A. Charlson, MD
Advertisement
Articles by John A. Charlson, MD
Advertisement
Latest Updated Articles
John A. Charlson, MD, on Afami-Cel’s Upcoming Review for Synovial SarcomaPublished: March 24th 2024 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
3
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
4
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
5
